Key Findings

The study identifies KPC-2, a class A carbapenem-hydrolyzing beta-lactamase, as the primary mechanism of carbapenem resistance in a clinical isolate of Klebsiella oxytoca. KPC-2 was shown to confer resistance to carbapenems, extended-spectrum cephalosporins, and aztreonam when cloned in E. coli.